Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls
- 8 June 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 5 (8) , 887-905
Abstract
The pharmaceutical relevance of proton-coupled peptide transporters is currently under intense investigation in many laboratories. Studies have shown that these membrane proteins, expressed in intestine, kidney, choroid plexus and other tissues, accept many peptidomimetic drugs and prodrugs as substrates. The focus of this review is on the interaction of ß-lactam antibiotics, angiotensin-converting enzyme inhibitors, sartans and other drugs with PEPT1 and PEPT2. The article highlights progress made in recent years and the most expedient techniques that have been or are being employed. It also emphasizes the opportunities in rational drug design that are of highest priority and the pitfalls that must be avoided. Finally, an instructional flowchart that might be used to identify a peptide transporter substrate is proposed.Keywords
This publication has 92 references indexed in Scilit:
- The mammalian proton-coupled peptide cotransporter PepT1: sitting on the transporter–channel fence?Philosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovirInternational Journal of Pharmaceutics, 2008
- Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitorInternational Journal of Pharmaceutics, 2008
- Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 TransportersMolecules, 2008
- The renal type H+/peptide symporter PEPT2: structure-affinity relationshipsAmino Acids, 2006
- The Role of an α-Amino Group on H+-dependent Transepithelial Transport of Cephalosporins in Caco-2 CellsJournal of Pharmacy and Pharmacology, 1999
- Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, ValacyclovirBiochemical and Biophysical Research Communications, 1998
- Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2Biochemical and Biophysical Research Communications, 1998
- Influence of proton and essential histidyl residues on the transport kinetics of the H+/peptide cotransport systems in intestine (PEPT 1) and kidney (PEPT 2)Biochimica et Biophysica Acta (BBA) - Biomembranes, 1997
- Transport of beta-lactam antibiotics in kidney brush border membrane. Determinants of their affinity for the oligopeptide/H+ symporter.Journal of Clinical Investigation, 1993